Skip to content

Randomized controlled clinical study on the effectiveness of wearing compound multi-point defocused lenses to delay myopia progression in children

Randomized controlled clinical study on the effectiveness of wearing compound multi-point defocused lenses to delay myopia progression in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085200
Enrollment
Unknown
Registered
2024-06-03
Start date
2024-06-03
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Intervention group:Wear Mingyue compound multi-point defocused lenses
Control group:Wear Mingyue asymmetric multi-point positive defocused lenses

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Age: 8~12 years old (including 8 and 12 years old); (2) binocular equivalent spherical lens: -0.75D~-4.00D; (3) binocular astigmatism =1.50D; (4) binocular spherical anisometropia = 1.50 D; (5) The best far-corrected visual acuity in both eyes =0.8 (+0.10LogMAR); (6) The refractive medium of the examined eye is clear; (7) No eye flutter in both eyes, with good fixation ability; (8) Stop wearing soft contact lenses for more than 1 week, and stop wearing hard contact lenses for more than 1 month; (9) Peripheral defocus lenses, point diffusion myopia control lenses, orthokeratology lenses and multi-focal contact lenses Stop wearing the mirror for more than 3 months; (10) Able to cooperate with various inspections.

Exclusion criteria

Exclusion criteria: (1) strabismus, amblyopia, nystagmus and other eye diseases; (2) adjustment dysfunction and/or non-strabismatic binocular dysfunction; (3) Shallow anterior chamber, narrow chamber Angle or IOP > 21mm Hg; (4) Suffering from eye diseases such as keratitis, pink eye, acute inflammation around the eye, and glaucoma; (5) Have used or are using low concentration atropine eye drops, feeding light meter; (6) Any history of eye surgery; (7) Persons with intellectual disability or mental illness; (8) cardiopulmonary insufficiency; (9) Patients with poor compliance who are considered inappropriate to participate in this clinical trial; (10) Participants who also participated in other myopia control tests.

Design outcomes

Primary

MeasureTime frame
Axial length;Cycloplegia automatic refraction spherical equivalent degree;

Secondary

MeasureTime frame
Adverse events;

Countries

China

Contacts

Public ContactLongqian Liu

West China Hospital of Sichuan University

bq15651@hotmail.com+86 189 8060 1759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026